IL101770A - History of amino acids, their production and pharmaceutical preparations containing them - Google Patents

History of amino acids, their production and pharmaceutical preparations containing them

Info

Publication number
IL101770A
IL101770A IL10177092A IL10177092A IL101770A IL 101770 A IL101770 A IL 101770A IL 10177092 A IL10177092 A IL 10177092A IL 10177092 A IL10177092 A IL 10177092A IL 101770 A IL101770 A IL 101770A
Authority
IL
Israel
Prior art keywords
tert
hydroxy
formula
butyl
amino
Prior art date
Application number
IL10177092A
Other languages
English (en)
Hebrew (he)
Other versions
IL101770A0 (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919110170A external-priority patent/GB9110170D0/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority to IL112900A priority Critical patent/IL112900A/xx
Publication of IL101770A0 publication Critical patent/IL101770A0/xx
Publication of IL101770A publication Critical patent/IL101770A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/24—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
    • C07C255/29—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton containing cyano groups and acylated amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measurement Of Force In General (AREA)
  • Confectionery (AREA)
  • Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Glass Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cleaning Or Clearing Of The Surface Of Open Water (AREA)
IL10177092A 1991-05-10 1992-05-04 History of amino acids, their production and pharmaceutical preparations containing them IL101770A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL112900A IL112900A (en) 1991-05-10 1992-05-04 Intermediates for the preparation of hiv protease inhibitors

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919110170A GB9110170D0 (en) 1991-05-10 1991-05-10 Amino acid derivatives
GB929203014A GB9203014D0 (en) 1991-05-10 1992-02-13 Amino acid derivatives

Publications (2)

Publication Number Publication Date
IL101770A0 IL101770A0 (en) 1992-12-30
IL101770A true IL101770A (en) 1996-06-18

Family

ID=26298885

Family Applications (3)

Application Number Title Priority Date Filing Date
IL112900A IL112900A (en) 1991-05-10 1992-05-04 Intermediates for the preparation of hiv protease inhibitors
IL10177092A IL101770A (en) 1991-05-10 1992-05-04 History of amino acids, their production and pharmaceutical preparations containing them
IL11290095A IL112900A0 (en) 1991-05-10 1995-03-07 Amino acid derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL112900A IL112900A (en) 1991-05-10 1992-05-04 Intermediates for the preparation of hiv protease inhibitors

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL11290095A IL112900A0 (en) 1991-05-10 1995-03-07 Amino acid derivatives

Country Status (24)

Country Link
US (2) US5430041A (cs)
EP (1) EP0512343B1 (cs)
JP (1) JPH06102639B2 (cs)
AT (1) ATE125792T1 (cs)
AU (1) AU660308B2 (cs)
CA (1) CA2067690C (cs)
CZ (1) CZ281839B6 (cs)
DE (1) DE69203780T2 (cs)
DK (1) DK0512343T3 (cs)
DZ (1) DZ1578A1 (cs)
ES (1) ES2075976T3 (cs)
FI (2) FI110938B (cs)
GR (1) GR3017902T3 (cs)
HR (1) HRP931025B1 (cs)
HU (1) HU210283B (cs)
IE (1) IE69169B1 (cs)
IL (3) IL112900A (cs)
IS (1) IS1747B (cs)
MX (1) MX9202146A (cs)
MY (1) MY108770A (cs)
NO (1) NO300496B1 (cs)
NZ (1) NZ242593A (cs)
RO (1) RO109540B1 (cs)
SK (1) SK281183B6 (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5413999A (en) * 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
CA2130754C (en) * 1992-03-11 2005-02-08 Damian W. Grobelny Amine derivatives of oxo- and hydroxy-substituted hydrocarbons
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
ATE253050T1 (de) 1992-03-11 2003-11-15 Narhex Ltd Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
US5733906A (en) * 1993-10-12 1998-03-31 Eli Lilly And Company Inhibitors of HIV Protease useful for the treatment of Aids
MX9308016A (es) * 1992-12-22 1994-08-31 Lilly Co Eli Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene.
US5491166A (en) * 1992-12-22 1996-02-13 Eli Lilly And Company Inhibitors of HIV protease useful for the treatment of AIDS
US5591885A (en) * 1994-09-23 1997-01-07 Hoffman-La Roche Inc. Process for the preparation of halogenated α-aminoketone compounds
US5523463A (en) * 1994-09-23 1996-06-04 Hoffmann-La Roche Inc. Method of producing halogenated and alpha-aminoalchohols
GB0123467D0 (en) 2001-09-28 2001-11-21 Hoffmann La Roche Carbocyclic HIV Protease inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE447633B (sv) * 1978-09-19 1986-12-01 Albany Int Corp Forfarande for separering och modul for genomforande av forfarandet
JPS63166826A (ja) * 1986-12-27 1988-07-11 Shin Etsu Chem Co Ltd 抗ヒトレトロウイルス剤
CA1340588C (en) * 1988-06-13 1999-06-08 Balraj Krishan Handa Amino acid derivatives
CA2010531A1 (en) * 1989-03-06 1990-09-06 Werner Neidhart Amino acid derivatives
CA2012901A1 (en) * 1989-04-05 1990-10-05 Quirico Branca Amino acid derivatives
GB8927913D0 (en) * 1989-12-11 1990-02-14 Hoffmann La Roche Amino acid derivatives
CN1071930A (zh) * 1991-07-10 1993-05-12 伊莱利利公司 用作治疗艾滋病的人免疫缺陷病毒蛋白酶的抑制剂

Also Published As

Publication number Publication date
EP0512343B1 (en) 1995-08-02
HUT61972A (en) 1993-03-29
DK0512343T3 (da) 1995-10-16
RO109540B1 (ro) 1995-03-30
MX9202146A (es) 1992-11-01
EP0512343A3 (en) 1993-03-24
CS138492A3 (en) 1992-11-18
NO300496B1 (no) 1997-06-09
JPH06102639B2 (ja) 1994-12-14
CA2067690A1 (en) 1992-11-11
DE69203780D1 (de) 1995-09-07
AU660308B2 (en) 1995-06-22
IL112900A (en) 1997-06-10
IS1747B (is) 2000-07-11
FI922094A0 (fi) 1992-05-08
SK281183B6 (sk) 2001-01-18
JPH05155834A (ja) 1993-06-22
EP0512343A2 (en) 1992-11-11
DE69203780T2 (de) 1995-12-07
ES2075976T3 (es) 1995-10-16
GR3017902T3 (en) 1996-01-31
FI990399A (fi) 1999-02-24
US5583248A (en) 1996-12-10
IS3858A (is) 1992-11-11
NZ242593A (en) 1994-06-27
HU9201514D0 (en) 1992-07-28
IL112900A0 (en) 1995-06-29
HU210283B (en) 1995-03-28
ATE125792T1 (de) 1995-08-15
HRP931025B1 (en) 2000-06-30
FI922094A (fi) 1992-11-11
IE921490A1 (en) 1992-11-18
AU1600792A (en) 1992-11-12
MY108770A (en) 1996-11-30
HRP931025A2 (en) 1996-06-30
US5430041A (en) 1995-07-04
CZ281839B6 (cs) 1997-02-12
NO921828D0 (no) 1992-05-08
FI110938B (fi) 2003-04-30
IE69169B1 (en) 1996-08-07
IL101770A0 (en) 1992-12-30
DZ1578A1 (fr) 2002-02-17
NO921828L (no) 1992-11-11
FI990399A0 (fi) 1999-02-24
CA2067690C (en) 2005-09-06

Similar Documents

Publication Publication Date Title
US5446161A (en) Amino acid derivatives
EP0432695B1 (en) Amino acid derivatives
EP0386611A2 (en) Amino acid derivatives
EP0512343B1 (en) Amino acid derivatives and their use as anti-viral agents
EP0574494A1 (en) Indoles useful as platelet activating factor antagonists
KR100220987B1 (ko) 아미노산 유도체, 이의 제조방법 및 이를 함유하는 약제
SI9200269A (sl) Derivati amino kislin
WO1995019958A1 (en) Malarial aspartic protease inhibitors
SI8911201A (sl) Derivati aminokislin

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees